Wendy Mallon

Rush University Medical CenterChicago, Illinois - 60612 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2008

Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade Therapy.
August 2008 - March 2011
Lymphoma
Lymphoma, Mantle-Cell
Rad001



